TrialAnnals of hematology2026

Acalabrutinib in patients with mantle cell lymphoma subjected to allogeneic hematopoietic cell transplantation. a phase 2 study by the Polish Lymphoma Research Group (PLRG12 trial).

Sebastian Giebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.